Gene signature to tailor chemotherapy shows promise for improving breast cancer survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainUsing a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to

Updated on: November 08,2024

Gene signature to tailor chemotherapy shows promise for improving breast cancer survival

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainUsing a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to

Updated on:November 08,2024

How conquering a rare leukemia in children revolutionized cancer care for millions

by Marie McculloughFifty years ago, children with an aggressive form of leukemia went from diagnosis to death in a few months, as the disease rampaged through their lymph nodes, spleens, livers, and n

Updated on: March 01,2024

How conquering a rare leukemia in children revolutionized cancer care for millions

by Marie McculloughFifty years ago, children with an aggressive form of leukemia went from diagnosis to death in a few months, as the disease rampaged through their lymph nodes, spleens, livers, and n

Updated on:March 01,2024

Global study predicts more than 50 percent rise in chemotherapy demand by 2040

byLancetCredit: CC0 Public DomainTo deliver optimal treatment by 2040, a significant expansion of the chemotherapy workforce is needed.Between 2018 and 2040, the number of patients requiri

Updated on: May 23,2024

Global study predicts more than 50 percent rise in chemotherapy demand by 2040

byLancetCredit: CC0 Public DomainTo deliver optimal treatment by 2040, a significant expansion of the chemotherapy workforce is needed.Between 2018 and 2040, the number of patients requiri

Updated on:May 23,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on: December 01,2024

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on:December 01,2024

New study identifies ganoderic acid DM as potential treatment for breast cancer

byChinese Academy of SciencesProtein-protein interaction network of the 53 potential targets for treating breast cancer. Credit: Mohammed Sharif SwallahBreast cancer is one of the most common ca

Updated on: October 22,2024

New study identifies ganoderic acid DM as potential treatment for breast cancer

byChinese Academy of SciencesProtein-protein interaction network of the 53 potential targets for treating breast cancer. Credit: Mohammed Sharif SwallahBreast cancer is one of the most common ca

Updated on:October 22,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on: March 01,2024

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on:March 01,2024

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

by Jeff Hansen,University of Alabama at BirminghamLudwine Messiaen, Ph.D., left, and Magdalena Koczkowska, Ph.D. Credit: University of Alabama at BirminghamInternational collaborative research l

Updated on: March 14,2024

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

by Jeff Hansen,University of Alabama at BirminghamLudwine Messiaen, Ph.D., left, and Magdalena Koczkowska, Ph.D. Credit: University of Alabama at BirminghamInternational collaborative research l

Updated on:March 14,2024

Researchers publish action plan to address appendiceal cancer enigmas

Updated on: April 29,2025

Researchers publish action plan to address appendiceal cancer enigmas

Updated on:April 29,2025

Study reveals secrets of "hot" and "cold" pancreatic cancer tumors

by Perelman School of Medicine at the University of PennsylvaniaT cell high tumor. T cell high tumor. All Cell/Tumor Cells/T Cells. Credit: Perelman School of Medicine at the University of Pennsy

Updated on: July 02,2024

Study reveals secrets of "hot" and "cold" pancreatic cancer tumors

by Perelman School of Medicine at the University of PennsylvaniaT cell high tumor. T cell high tumor. All Cell/Tumor Cells/T Cells. Credit: Perelman School of Medicine at the University of Pennsy

Updated on:July 02,2024

Chemo drug may cause significant hearing loss in longtime cancer survivors

byUniversity of South FloridaCredit: Unsplash/CC0 Public DomainAn interdisciplinary study led by researchers at the University of South Florida and Indiana University has uncovered significant f

Updated on: July 08,2024

Chemo drug may cause significant hearing loss in longtime cancer survivors

byUniversity of South FloridaCredit: Unsplash/CC0 Public DomainAn interdisciplinary study led by researchers at the University of South Florida and Indiana University has uncovered significant f

Updated on:July 08,2024

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on: May 25,2024

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on:May 25,2024

More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA survey of nearly 50,000 cancer survivors has found that more than a quarter had a physical disability that impaired their mobili

Updated on: April 30,2024

More than 25% of cancer survivors report significant levels of disability after cancer diagnosis, according to new study

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA survey of nearly 50,000 cancer survivors has found that more than a quarter had a physical disability that impaired their mobili

Updated on:April 30,2024